Core Viewpoint - The news summarizes important announcements from various companies, highlighting stock suspensions, significant profit growth, and major contracts signed, which may present investment opportunities and insights into market trends [1][2]. Stock Suspensions - *ST Zhengping announced that its stock will be suspended from trading starting October 29, 2025, due to a significant price increase of 152.42% from September 1 to October 28, 2025, and abnormal trading fluctuations [3]. - Gongjin Co. announced a stock suspension starting October 27, 2025, due to the major shareholder planning a share transfer that may lead to a change in control [4]. Investment Activities - Juyuan Technology's subsidiary plans to invest 150 million yuan in establishing an industrial fund focused on chips, integrated circuits, and other high-growth sectors [5]. - YN Holdings decided to terminate investments in 17 distributed photovoltaic projects, originally planned to cost 1.197 billion yuan, due to changes in market conditions [6]. Earnings Reports - Suliy Co. reported a 2750% increase in net profit for Q3 2025, with revenue of 762 million yuan, up 26% year-on-year [8]. - Xianda Co. reported a net profit of 59.85 million yuan for Q3 2025, a 5447% increase, despite a 5.59% decline in revenue [9]. - Yutong Bus reported a net profit of 1.357 billion yuan for Q3 2025, a 78.98% increase, with revenue of 10.237 billion yuan, up 32.27% [10]. - Juxin Technology reported a net profit of 60.27 million yuan for Q3 2025, a 101.09% increase, with revenue of 273 million yuan, up 46.64% [11]. - Guanghong Technology reported a net profit of 99.61 million yuan for Q3 2025, a 99.68% increase, with revenue of 2.937 billion yuan, up 57.46% [12]. - Mingzhi Electric reported a net profit of 22.88 million yuan for Q3 2025, a 215.97% increase, with revenue of 729 million yuan, up 28.98% [13]. - Zhongwei Semiconductor reported a net profit of 65.82 million yuan for Q3 2025, a 3.66% decrease, with revenue of 269 million yuan, up 21.88% [14]. - Yiming Pharmaceutical reported a net profit of 44.21 million yuan for Q3 2025, a 1934.12% increase, with revenue of 178 million yuan, up 10.37% [15]. - Weilan Bio reported a net profit of 35.06 million yuan for Q3 2025, a 205.02% increase, with revenue of 364 million yuan, up 8.09% [16]. - Baiyunshan reported a net profit of 794 million yuan for Q3 2025, a 30.28% increase, with revenue of 19.771 billion yuan, up 9.74% [17]. - Giant Network reported a net profit of 640 million yuan for Q3 2025, an 81.19% increase, with revenue of 1.706 billion yuan, up 115.63% [18]. Share Buybacks - Haida Group announced a plan to repurchase shares worth between 1 billion and 1.6 billion yuan, aimed at reducing registered capital and implementing employee stock ownership plans [20]. Major Contracts - Bai'ao Intelligent announced it won a project worth 97.22 million yuan from a large state-owned company [22]. - Guangdong Construction signed a construction contract worth 1.924 billion yuan for a project in Guangzhou, with a duration of 1365 days [23][24].

每经AI快讯，*ST赛隆（SZ 002898，收盘价：14.09元）10月28日晚间发布公告称，公司第四届第十七 次董事会会议于2025年10月27日在湖南省长沙市长沙县星沙产业基地红枫路1号湖南赛隆药业（长沙） 有限公司会议室以现场及通讯相结合的方式召开。会议审议了《关于公司2025年第三季度报告的议案》 等文件。 每经头条（nbdtoutiao）——A股突破4000点！十年沉寂终迎爆发，科技主线重塑市场，"慢牛"新格局开 启！ （记者 胡玲） 2025年1至6月份，*ST赛隆的营业收入构成为：医药制造业占比59.82%，电子行业占比39.78%，其他业 务占比0.4%。 截至发稿，*ST赛隆市值为25亿元。 ...

数据显示，企业R&D经费占比持续提升，创新主体作用进一步彰显。分活动主体看，各类企业研 究与试验发展（R&D）经费1558.6亿元，比上年增长13.5%；政府属研究机构经费1219.1亿元，增长 9.1%；高等学校经费410.7亿元，增长12.2%；其他主体经费90.0亿元，下降0.9%。企业、政府属研究机 构、高等学校经费所占比重分别为47.5%、37.2%和12.5%。 分行业看，规模以上信息传输、软件和信息技术服务业R&D经费735.0亿元，比上年增长6.3%，其 中软件和信息技术服务业经费566.8亿元，增长30.2%；规模以上工业企业R&D经费467.7亿元，增长 6.1%，其中高技术制造业经费297.3亿元。规模以上工业企业中，R&D经费投入超过10亿元的行业大类 有8个，与上年保持一致，这8个行业经费占全部规模以上工业企业R&D经费的比重为90.4%。重点领域 R&D经费投入快速增长，医药制造业，专用设备制造业，汽车制造业，计算机、通信和其他电子设备 制造业作为R&D经费投入的主要支柱行业，经费合计占规模以上工业企业的76.5%，较上年提高1.4个百 分点。其中，专用设备制造业R&D经费为53. ...

Core Insights - Baihua Pharmaceutical (600721.SH) reported a total operating revenue of 299 million yuan for Q3 2025, with a net profit attributable to shareholders of 32.67 million yuan [1] - The company's net cash inflow from operating activities was 12.36 million yuan, a decrease of 47.66 million yuan compared to the same period last year, representing a year-on-year decline of 79.40% [1] Financial Metrics - The latest debt-to-asset ratio stands at 29.16% [3] - The latest gross profit margin is 49.16%, a decrease of 0.24 percentage points from the previous quarter [3] - The latest return on equity (ROE) is 4.12% [3] - The diluted earnings per share (EPS) is 0.09 yuan [3] - The total asset turnover ratio is 0.27 times, and the inventory turnover ratio is 1.74 times [3] Shareholder Information - The number of shareholders is 33,200, with the top ten shareholders holding a total of 135 million shares, accounting for 35.05% of the total share capital [3] - The top ten shareholders and their respective holdings are as follows: - Mi Zaiqi: 8.99% - Mi Enhua: 6.70% - Yang Xiaoling: 4.95% - Xinjiang Xinnong Modern Investment Development Co., Ltd.: 4.36% - Li Jiancheng: 3.90% - Zhang Desheng: 2.12% - Ningbo Meishan Free Trade Port Area Daokang Xiangyun Investment Partnership (Limited Partnership): 1.28% - Shanghai Jiaqi Asset Management Center (Limited Partnership): 0.99% - China Securities Investor Protection Fund Co., Ltd.: 0.89% - Xinjiang Bingshe Material Management Co., Ltd.: 0.80% [3]

Core Insights - The best-performing fund managed by Hu Zhili is the Industrial Bank Technology Innovation Mixed Fund (007353), with a quarterly net value increase of 53.44% as of Q3 2025 [1] Fund Performance Summary - Hu Zhili manages a total of 9 funds, with the following notable performances: - Industrial Bank Leading Three-Year Holding Mixed Fund: 25.46 billion CNY, annualized return of 13.79%, Q1 2025 increase of 27.02% [2] - Industrial Bank Shanghai-Hong Kong Stock A: 60.8 billion CNY, annualized return of 2.36%, Q1 2025 increase of 16.90% [2] - Industrial Bank Technology Innovation Mixed Fund: 5.67 billion CNY, annualized return of 14.02%, Q1 2025 increase of 53.44% [2] - Industrial Bank Quality Selected Mixed A: 2.03 billion CNY, annualized return of 10.25%, Q1 2025 increase of 25.81% [2] Stock Trading Performance - Hu Zhili's management of the Industrial Bank Quality Selected Mixed A Fund has yielded a cumulative return of 147.92% with an average annualized return of 10.92% [2] - The fund has made 82 adjustments to its heavy-weight stocks, achieving a win rate of 65.85% with 54 profitable trades [2] Notable Stock Adjustments - Significant stock adjustments include: - Zhirun Co., Ltd.: Held from Q1 2020 to Q2 2021, with a performance increase of 34.66% and an estimated return of 304.28% [3] - Mindray Medical: Held from Q4 2019 to Q1 2021, with a performance increase of 70.95% and an estimated return of 132.14% [3] - Ganfeng Lithium: Held from Q2 2020 to Q2 2021, with a performance increase of 410.26% and an estimated return of 129.42% [3] Underperforming Stocks - Underperforming stocks include: - Zijin Mining: Held from Q1 2024 to Q4 2024, with an estimated return of -87.79% despite a performance increase of 51.76% [4] - Jiu Gui Jiu: Held from Q3 2021 to Q4 2022, with an estimated return of -45.05% [4] - Bai Run Co., Ltd.: Held from Q3 2021 to Q1 2022, with an estimated return of -40.92% [4]

10月28日，有2只新股申购，分别是沪市主板的德力佳（603092）(603092.SH)，以及北交所的中诚咨询 (920003.BJ)；另有4只新股上市，为科创板的必贝特(688759.SH)、西安奕材(688783.SH)、禾元生物 (688765.SH)和北交所的泰凯英(920020.BJ)。 2只新股申购 德力佳主要从事高速重载精密齿轮传动产品的研发、生产与销售，下游应用领域目前主要为风力发电机 组，核心产品为风电主齿轮箱。 打新早知道 cally Design | | 今日申购 | | | | --- | --- | --- | --- | | | 603092.SH 德力佳 | | | | 发行价(元/股) | 机构报价(元/股) | 市值(亿元) | 所属行业 | | 46.68 | 47.68 | 168.00 | 通用设备制造业 | | 发行市盈率 | 行业市盈率 | 可以公司 | 可比公司动态市盈率 | | 34.98 | 44.03 | 杭齿前进 | 28.30 21.41 | | | | 大连重 | | | | | 威力传动 | 亏损 | | | 业绩情况 | | | | 50.0 | ...

每经头条（nbdtoutiao）——拉1人入伙返1500元，投10万元成亿万富翁？这家公司大肆宣传将房产海外 代币化，有交了钱的人称是"牙签撬动地球" （记者 王晓波） 每经AI快讯，富祥药业（SZ 300497，收盘价：10.1元）10月27日晚间发布公告称，公司第五届第三次 董事会会议于2025年10月27日在景德镇市昌江区鱼丽工业区2号公司三楼会议室召开。会议审议了 《2025年第三季度报告》等文件。 2024年1至12月份，富祥药业的营业收入构成为：医药制造业占比77.94%，锂电池电解液添加剂占比 21.45%，CDMO占比0.61%。 截至发稿，富祥药业市值为54亿元。 ...

今日聚焦 1、北方稀土：前三季度净利润同比增长280% 稀土产品销量增加 北方稀土发布2025年三季报，第三季度营收为114.25亿元，同比增长33.32%；净利润6.1亿元，同比增 长69.48%。前三季度营收为302.92亿元，同比增长40.50%；净利润15.41亿元，同比增长280.27%。报告 期内，公司主要产品的销售价格同比升高，销量同比增加，毛利同比增加。 2、邮储银行：获准筹建金融资产投资公司 注册资本为100亿元 邮储银行公告，近日收到国家金融监督管理总局批复，同意本行筹建中邮金融资产投资有限公司。中邮 投资注册资本为人民币100亿元，将作为邮储银行全资一级子公司进行管理。筹建完成后，邮储银行将 申请开业。设立中邮投资旨在提升综合服务能力，通过市场化债转股及股权投资试点，支持科技创新和 民营企业，助力新质生产力发展，推动高质量发展。 3、赛力斯：本次H股发行的价格最高不超过每股131.5港元 赛力斯公告，公司本次全球发售H股基础发行股数为100200000股（视乎发售量调整权及超额配售权行 使与否而定），其中，初步安排香港公开发售10020000股（可予重新分配及视乎发售量调整权行使与否 而 ...

证券研究报告 2025 年 10 月 27 日 星期一 【新股发行跟踪（20251027）】 一、上周新股表现情况 上周（10 月 20 日-10 月 24 日）共有 2 只新股上市，上市首日涨跌幅 均值为 263.20%。其中，有 2 只新股上市首日涨幅超 100%，为超颖电子、 马可波罗。 资料来源：东莞证券研究所，iFinD 二、周度新股上市情况走势 从周度新股上市规模来看，上周（10 月 20 日-10 月 24 日，下同）较 上上周（10 月 13 日-10 月 17 日，下同）相比，上市新股数量不变，首发 募资金额增加 15.91 亿元。 从周度上市新股表现来看，上上周无新股首日破发。 资料来源：东莞证券研究所，iFinD 本报告的风险等级为中高风险。 本报告的信息均来自已公开信息，关于信息的准确性与完整性，建议投资者谨慎判断，据此入市，风险自担。请务必阅读 末页声明。 1 表 1：上周新股表现 股票代码 股票简称 上市日期 上市 板块 发行价 格（元） 发行市 盈率 证监会行业 首日收盘 涨跌幅(%) 603175.SH 超颖电子 2025-10-24 主板 17.08 28.64 计算机、通信 ...

根据上海证券交易所发布的《上市公司行业信息披露指引第六号——医药制造》的 要求，现将浙江诚意药业股份有限公司（以下简称"公司"）2025 年第三季度主要经营 数据披露如下： 一、报告期内，公司主营业务分行业、分产品经营情况： | | | | | | 主营业务分行业情况 | | | | | | --- | --- | --- | --- | --- | --- | --- | | 分行业 | 营业收入 | 营业成本 | 毛利率（%） | 营业收入 比上年增 | 营业成本 比上年增 | 毛 利 率 比 上 年增减（%） | | | | | | 减（%） | 减（%） | | | 医药制造业 | 596,506,628.05 | 173,293,477.48 | 70.95 | 14.87 | 8.18 | 1.80 | | | | 主营业务分产品情况 | | | | | | 分产品 | 营业收入 | 营业成本 | 毛利率（%） | 营业收入 比上年增 减（%） | 营业成本 比上年增 减（%） | 毛利率比上 年增减（%） | | 制剂 | 496,513,404.00 | 118,393,845.78 | 76 ...